关于儿童群体中安福特素B脱氧酸盐过量服用的已公布病例的综述和病例报告
Marzieh Shahrabi1, Sana Savadi2, Yousef Tavakolifar3
1Department of Clinical Pharmacy, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
Current drug safety
|October 17, 2024
概括
错误地注射安波特素B脱氧酸盐可能会导致严重的并发症. 积极的心脏和液体监测对于儿童患者的过量治疗至关重要,确保稳定的结果.
科学领域:
- 药理学 药理学是指药理学的学科.
- 儿科医学 儿科医学
- 临床毒理学 临床毒理学
背景情况:
- 两种常见的安福特里辛B配方很容易混,导致药物错误.
- 缺乏对儿童安福特里辛B过量剂量的管理的综合性审查.
研究的目的:
- 审查和综合有关儿科患者安二乙过量管理的现有数据.
- 讨论安福特素B脱氧酸盐过量治疗的儿科病例的管理和结果.
主要方法:
- 对PubMed和谷歌学者进行系统审查,以查看报告的安二乙过量用药的病例.
- 详细的病例报告,一个8岁的患有尤文肉瘤的儿科患者,他服用了安福特素B脱氧酸盐的五倍过量.
主要成果:
- 确定并审查了十个相关案件.
- 儿科病例接受了积极的液体和电解质管理和七天的心脏监测.
- 患者在稳定的状态下出院.
结论:
- 过量服用安福特 B 脱氧化酸盐可能会导致严重的毒性,包括心脏毒性和电解质失衡,可能导致死亡.
- 积极监测和管理心脏功能,液体和电解质对于有利的结果至关重要.
- 需要进一步研究N-乙半氨酸 (NAC) 和皮在管理安二乙脱氧酸盐过量剂量的作用.
相关概念视频
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmaceutical Poisoning: Potential Scenarios
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Pharmaceutical Poisoning: Treatment Strategies
Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
Antifungal Agents
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...


